Martin E. Cearnal - Mar 17, 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Sr VP/Chief Commercial Officer, Director
Signature
Martin E. Cearnal by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Mar 17, 2021
Transactions value $
$27,022
Form type
4
Date filed
6/8/2021, 05:22 PM
Next filing
Jul 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Tax liability -$9.48K -2.95K -1.94% $3.22 149K Mar 17, 2021 Direct F1
transaction CPIX Common Stock Purchase $318 +105 +0.07% $3.03 149K Apr 16, 2021 Direct F2
transaction CPIX Common Stock Purchase $319 +105 +0.07% $3.04 149K Apr 19, 2021 Direct F2
transaction CPIX Common Stock Purchase $317 +105 +0.07% $3.02 149K Apr 20, 2021 Direct F2
transaction CPIX Common Stock Purchase $312 +105 +0.07% $2.97 149K Apr 21, 2021 Direct F2
transaction CPIX Common Stock Purchase $311 +105 +0.07% $2.96 149K Apr 22, 2021 Direct F2
transaction CPIX Common Stock Purchase $314 +105 +0.07% $2.99 149K Apr 23, 2021 Direct F2
transaction CPIX Common Stock Purchase $312 +105 +0.07% $2.97 150K Apr 26, 2021 Direct F2
transaction CPIX Common Stock Purchase $309 +105 +0.07% $2.94 150K Apr 27, 2021 Direct F2
transaction CPIX Common Stock Purchase $235 +80 +0.05% $2.94 150K Apr 28, 2021 Direct F2
transaction CPIX Common Stock Purchase $303 +105 +0.07% $2.89 150K Apr 29, 2021 Direct F2
transaction CPIX Common Stock Purchase $292 +105 +0.07% $2.78 150K Apr 30, 2021 Direct F2
transaction CPIX Common Stock Purchase $279 +105 +0.07% $2.66 150K May 3, 2021 Direct F2
transaction CPIX Common Stock Purchase $279 +105 +0.07% $2.66 150K May 4, 2021 Direct F2
transaction CPIX Common Stock Purchase $287 +105 +0.07% $2.73 150K May 5, 2021 Direct F2
transaction CPIX Common Stock Purchase $288 +105 +0.07% $2.74 150K May 6, 2021 Direct F2
transaction CPIX Common Stock Purchase $287 +105 +0.07% $2.73 150K May 7, 2021 Direct F2
transaction CPIX Common Stock Purchase $285 +105 +0.07% $2.71 151K May 10, 2021 Direct F2
transaction CPIX Common Stock Purchase $281 +105 +0.07% $2.68 151K May 11, 2021 Direct F2
transaction CPIX Common Stock Purchase $300 +105 +0.07% $2.86 151K May 12, 2021 Direct F2
transaction CPIX Common Stock Purchase $302 +105 +0.07% $2.88 151K May 13, 2021 Direct F2
transaction CPIX Common Stock Purchase $295 +105 +0.07% $2.81 151K May 14, 2021 Direct F2
transaction CPIX Common Stock Purchase $13.9K +5K +3.31% $2.77 156K May 14, 2021 Direct F3
transaction CPIX Common Stock Purchase $298 +105 +0.07% $2.84 156K May 17, 2021 Direct F2
transaction CPIX Common Stock Purchase $16.1K +5.7K +3.65% $2.83 162K May 17, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPIX Options (right to buy) Award $0 +5K $0.00 5K Mar 17, 2021 Common Stock 5K $3.22 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.
F2 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.715 to $2.792, inclusive. The reporting person undertakes to provide to Cumberland Pharmaceuticals Inc., any security holder of Cumberland Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.805 to $2.8797, inclusive.
F5 100% vesting on March 17, 2025.